siRNA-mediated knockdown of snoRA42 in CD133+ cells led to a significant decrease in transcript levels of the genes, including Oct4, Nanog, Sox2, Notch1, Smo, and ABCG2 compared to scrambled siRNA-treated CD133+ cancer cells (Figure 6). The gene discussed is SOX2; the disease is cancer.